Skip to main content

Advertisement

SpringerLink
Log in

Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rogers KA, Woyachn JA (2016) Secondary autoimmune cytopenias in chronic lymphocytic leukemia. Semin Oncol 43:300–310

    Article  PubMed  Google Scholar 

  2. Tsang M, Parikh SA (2017) A concise review of autoimmune cytopenias in chronic lymphocytic leukemia. Curr Hematol Malig rep 12(1):29–38

    Article  PubMed  Google Scholar 

  3. Seymour JF, Ma S, Brander DM et al (2017) Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. Lancet Oncol 18(2):230–240

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mato AR, Hill BT, Lamanna N et al. Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. Ann Oncol 2017 mdx031.

  5. Montillo M, O'Brien S, Tedeschi A et al (2017) Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study. Blood Cancer J 7(2):e524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Disciplina de Hematologia, Universidade Federal de São Paulo (UNIFESP), R. Diogo de Faria, 824, São Paulo, Brazil

    Marcelo Pitombeira de Lacerda, Nayara Ribeiro Guedes, Patricia Eiko Yamakawa, Andre Domingues Pereira, Ana Rita Brito Medeiros da Fonseca, Maria Lourdes Lopes Ferrari de Chauffaille, Matheus Vescovi Goncalves, Mihoko Yamamoto & Celso Arrais Rodrigues

Authors
  1. Marcelo Pitombeira de Lacerda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nayara Ribeiro Guedes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia Eiko Yamakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andre Domingues Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Rita Brito Medeiros da Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria Lourdes Lopes Ferrari de Chauffaille
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Matheus Vescovi Goncalves
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mihoko Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Celso Arrais Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Disclosure

No funding was received for this work. Lacerda MP has received speaker fees from Abbvie. The remaining authors have declared no conflicts of interest. Informed consent was obtained from the patient.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lacerda, M.P., Guedes, N.R., Yamakawa, P. et al. Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p). Ann Hematol 96, 1577–1578 (2017). https://doi.org/10.1007/s00277-017-3039-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3039-1

Search

Navigation